IBDEI0E9 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6494,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,6494,1,5,0)
 ;;=5^Hx Of Kidney Stone
 ;;^UTILITY(U,$J,358.3,6494,2)
 ;;=^303403
 ;;^UTILITY(U,$J,358.3,6495,0)
 ;;=302.71^^31^411^33
 ;;^UTILITY(U,$J,358.3,6495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6495,1,4,0)
 ;;=4^302.71
 ;;^UTILITY(U,$J,358.3,6495,1,5,0)
 ;;=5^Loss Of Libido
 ;;^UTILITY(U,$J,358.3,6495,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,6496,0)
 ;;=596.54^^31^411^37
 ;;^UTILITY(U,$J,358.3,6496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6496,1,4,0)
 ;;=4^596.54
 ;;^UTILITY(U,$J,358.3,6496,1,5,0)
 ;;=5^Neurogenic Bladder 
 ;;^UTILITY(U,$J,358.3,6496,2)
 ;;=^304798
 ;;^UTILITY(U,$J,358.3,6497,0)
 ;;=788.43^^31^411^38
 ;;^UTILITY(U,$J,358.3,6497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6497,1,4,0)
 ;;=4^788.43
 ;;^UTILITY(U,$J,358.3,6497,1,5,0)
 ;;=5^Nocturia
 ;;^UTILITY(U,$J,358.3,6497,2)
 ;;=^84740
 ;;^UTILITY(U,$J,358.3,6498,0)
 ;;=605.^^31^411^41
 ;;^UTILITY(U,$J,358.3,6498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6498,1,4,0)
 ;;=4^605.
 ;;^UTILITY(U,$J,358.3,6498,1,5,0)
 ;;=5^Phimosis
 ;;^UTILITY(U,$J,358.3,6498,2)
 ;;=^104159
 ;;^UTILITY(U,$J,358.3,6499,0)
 ;;=601.0^^31^411^43
 ;;^UTILITY(U,$J,358.3,6499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6499,1,4,0)
 ;;=4^601.0
 ;;^UTILITY(U,$J,358.3,6499,1,5,0)
 ;;=5^Prostatitis, Acute
 ;;^UTILITY(U,$J,358.3,6499,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,6500,0)
 ;;=590.10^^31^411^45
 ;;^UTILITY(U,$J,358.3,6500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6500,1,4,0)
 ;;=4^590.10
 ;;^UTILITY(U,$J,358.3,6500,1,5,0)
 ;;=5^Pyelonephritis, Acute
 ;;^UTILITY(U,$J,358.3,6500,2)
 ;;=^270369
 ;;^UTILITY(U,$J,358.3,6501,0)
 ;;=590.00^^31^411^46
 ;;^UTILITY(U,$J,358.3,6501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6501,1,4,0)
 ;;=4^590.00
 ;;^UTILITY(U,$J,358.3,6501,1,5,0)
 ;;=5^Pyelonephritis, Chronic
 ;;^UTILITY(U,$J,358.3,6501,2)
 ;;=^270367
 ;;^UTILITY(U,$J,358.3,6502,0)
 ;;=788.7^^31^411^55
 ;;^UTILITY(U,$J,358.3,6502,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6502,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,6502,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,6502,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,6503,0)
 ;;=131.02^^31^411^58
 ;;^UTILITY(U,$J,358.3,6503,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6503,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,6503,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,6503,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,6504,0)
 ;;=597.80^^31^411^57
 ;;^UTILITY(U,$J,358.3,6504,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6504,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,6504,1,5,0)
 ;;=5^Urethritis, NOS
 ;;^UTILITY(U,$J,358.3,6504,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,6505,0)
 ;;=788.41^^31^411^60
 ;;^UTILITY(U,$J,358.3,6505,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6505,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,6505,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,6505,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,6506,0)
 ;;=788.31^^31^411^63
 ;;^UTILITY(U,$J,358.3,6506,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6506,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,6506,1,5,0)
 ;;=5^Urinary Incontinence, Urge
 ;;^UTILITY(U,$J,358.3,6506,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,6507,0)
 ;;=788.20^^31^411^64
 ;;^UTILITY(U,$J,358.3,6507,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6507,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,6507,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,6507,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,6508,0)
 ;;=112.2^^31^411^67
 ;;^UTILITY(U,$J,358.3,6508,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6508,1,4,0)
 ;;=4^112.2
 ;;
 ;;$END ROU IBDEI0E9
